XT
BCAX

XTX Topco’s Bicara Therapeutics BCAX Stock Holding History

XTX Topco’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
+58,983
New +$1.32M 0.02% 1247
2026
Q1 		– Sell
-34,067
Closed -$573K – 4523
2025
Q4 		$573K Sell
34,067
-3,707
-10% -$63.3K 0.02% 1478
2025
Q3 		$596K Buy
37,774
+5,360
+17% +$60K 0.03% 939
2025
Q2 		$301K Buy
32,414
+3,961
+14% +$47.2K 0.01% 1433
2025
Q1 		$371K Buy
28,453
+1,119
+4% +$14.9K 0.02% 1249
2024
Q4 		$476K Buy
+27,334
New +$569K 0.04% 803

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's BCAX Position: Q2 2026 in Review

XTX Topco opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 58,983 shares worth $1.75M. The stake represents 0.02% of the portfolio and ranks #1247 among its holdings. This is a return to the name: XTX Topco previously reported a position in BCAX as recently as Q4 2025.

XTX Topco first reported a position in BCAX in Q4 2024 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • XTX Topco held 58,983 shares of Bicara Therapeutics worth $1.75M as of Q2 2026.
  • Bicara Therapeutics was a new XTX Topco position in Q2 2026.
  • Bicara Therapeutics made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1247 holding.
  • XTX Topco first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.